(Q41501609)

1 October 2017

1 reference

title

Combination of second-line antirheumatic drugs (English)

1 reference

1 October 2017

Haagsma CJ

1

1 reference

1 October 2017

van Riel PL

series ordinal

2

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 April 1997

1 reference

1 October 2017

1 reference

1 October 2017

volume

29

1 reference

1 October 2017

issue

2

1 reference

1 October 2017

page(s)

169-173

1 reference

The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial.

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853899709113706

Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899709113706

Therapy for rheumatoid arthritis: combinations of disease-modifying drugs and new paradigms of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899709113706

Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899709113706

Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899709113706

Combination therapy with methotrexate and chloroquine in rheumatoid arthritis. A multicenter randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899709113706

The cycling of combination antirheumatic drug therapy in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899709113706

Sulphasalazine in rheumatoid arthritis: combination therapy with D-penicillamine or sodium aurothiomalate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899709113706

The use of combinations of disease-modifying antirheumatic agents in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899709113706

Co-trimoxazole in rheumatoid arthritis: a comparison with sulphapyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899709113706

Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899709113706

Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899709113706

The efficacy and toxicity of combination therapy in rheumatoid arthritis. a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899709113706

Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899709113706

10.3109/07853899709113706

21 January 2018

Identifiers

DOI

1 reference

release_7f3fcbbhozhahil27hokk2n5ya

1 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7f3fcbbhozhahil27hokk2n5ya

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference